Update on the pathobiology of neuropathic pain

References

• Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet353(9168), 1959–1964 (1999).
   PubMed Web of Science ®Google Scholar
• Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain73(2), 123–139 (1997).
   PubMed Web of Science ®Google Scholar
• Koltzenburg M. Painful neuropathies. Curr. Opin. Neurol.11(5), 515–521 (1998).
   PubMedGoogle Scholar
• Dray A. Neuropathic pain: emerging treatments. Br. J. Anaesth.101(1), 48–58 (2008).
   PubMed Web of Science ®Google Scholar
• Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron52(1), 77–92 (2006).
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain83(3), 389–400 (1999).
   PubMed Web of Science ®Google Scholar
• Hansson PT, Dickenson AH. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain113(3), 251–254 (2005).
   PubMed Web of Science ®Google Scholar
• Chen H, Lamer TJ, Rho RH et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin. Proc.79(12), 1533–1545 (2004).
   PubMed Web of Science ®Google Scholar
• Orth AP, Batalov S, Perrone M, Chanda SK. The promise of genomics to identify novel therapeutic targets. Expert Opin. Ther. Targets8(6), 587–596 (2004).
   PubMed Web of Science ®Google Scholar
• Banks RE, Dunn MJ, Hochstrasser DF et al. Proteomics: new perspectives, new biomedical opportunities. Lancet356(9243), 1749–1756 (2000).
   PubMed Web of Science ®Google Scholar
• Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci.27(5), 251–259 (2006).
   PubMed Web of Science ®Google Scholar
• Brehmer D, Godl K, Zech B, Wissing J, Daub H. Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors. Mol. Cell. Proteomics3(5), 490–500 (2004).
   PubMed Web of Science ®Google Scholar
• Niederberger E, Geisslinger G. Proteomics in neuropathic pain research. Anesthesiology108(2), 314–323 (2008).
   PubMed Web of Science ®Google Scholar
• Wang LX, Wang ZJ. Animal and cellular models of chronic pain. Adv. Drug Deliv. Rev.55(8), 949–965 (2003).
   PubMed Web of Science ®Google Scholar
• Hu SJ, Xing JL. An experimental model for chronic compression of dorsal root ganglion produced by intervertebral foramen stenosis in the rat. Pain77(1), 15–23 (1998).
   PubMed Web of Science ®Google Scholar
• Song XJ, Hu SJ, Greenquist KW, Zhang JM, LaMotte RH. Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia. J. Neurophysiol.82(6), 3347–3358 (1999).
   PubMed Web of Science ®Google Scholar
• Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain87(2), 149–158 (2000).
   PubMed Web of Science ®Google Scholar
• Rivera L, Gallar J, Pozo MA, Belmonte C. Responses of nerve fibres of the rat saphenous nerve neuroma to mechanical and chemical stimulation: an in vitro study. J. Physiol.527 Pt 2, 305–313 (2000).
   PubMedGoogle Scholar
• Huang HL, Cendan CM, Roza C et al. Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves. Mol. Pain4(1), 33 (2008).
   PubMedGoogle Scholar
• Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain50(3), 355–363 (1992).
   PubMed Web of Science ®Google Scholar
• Choi Y, Yoon YW, Na HS, Kim SH, Chung JM. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain59(3), 369–376 (1994).
   PubMed Web of Science ®Google Scholar
• Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain43(2), 205–218 (1990).
   PubMed Web of Science ®Google Scholar
• Tahmoush AJ. Causalgia: redefinition as a clinical pain syndrome. Pain10(2), 187–197 (1981).
   PubMed Web of Science ®Google Scholar
• Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain33(1), 87–107 (1988).
   PubMed Web of Science ®Google Scholar
• George A, Marziniak M, Schafers M, Toyka KV, Sommer C. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain88(3), 267–275 (2000).
   PubMed Web of Science ®Google Scholar
• Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol.429(1–3), 23–37 (2001).
   PubMed Web of Science ®Google Scholar
• Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum. Psychopharmacol.19(Suppl. 1), S15–S19 (2004).
   Web of Science ®Google Scholar
• Wagner R, Janjigian M, Myers RR. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression. Pain74(1), 35–42 (1998).
   PubMed Web of Science ®Google Scholar
• Jimenez CR, Stam FJ, Li KW et al. Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration. Mol. Cell. Proteomics4(2), 120–132 (2005).
   PubMed Web of Science ®Google Scholar
• Bester H, Beggs S, Woolf CJ. Changes in tactile stimuli-induced behavior and c-Fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush. J. Comp. Neurol.428(1), 45–61 (2000).
   PubMed Web of Science ®Google Scholar
• Greenberg J, McKeever PE, Balentine JD. Lysosomal activity in experimental spinal cord trauma: an ultrastructural cytochemical evaluation. Surg. Neurol.9(6), 361–364 (1978).
   PubMedGoogle Scholar
• Anderson TE. A controlled pneumatic technique for experimental spinal cord contusion. J. Neurosci. Methods6(4), 327–333 (1982).
   PubMed Web of Science ®Google Scholar
• Tarlov IM. Acute spinal cord compression paralysis. J. Neurosurg.36(1), 10–20 (1972).
   PubMed Web of Science ®Google Scholar
• Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg. Neurol.10(1), 38–43 (1978).
   PubMedGoogle Scholar
• Watson BD, Prado R, Dietrich WD, Ginsberg MD, Green BA. Photochemically induced spinal cord injury in the rat. Brain Res.367(1–2), 296–300 (1986).
   PubMedGoogle Scholar
• Hao JX, Xu XJ, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. Photochemically induced transient spinal ischemia induces behavioral hypersensitivity to mechanical and cold stimuli, but not to noxious-heat stimuli, in the rat. Exp. Neurol.118(2), 187–194 (1992).
   PubMedGoogle Scholar
• Gorman AL, Yu CG, Ruenes GR, Daniels L, Yezierski RP. Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J. Pain2(4), 229–240 (2001).
   PubMedGoogle Scholar
• Wilcox GL. Pharmacological studies of grooming and scratching behavior elicited by spinal substance P and excitatory amino acids. Ann. NY Acad. Sci.525, 228–236 (1988).
   PubMedGoogle Scholar
• Christensen MD, Hulsebosch CE. Chronic central pain after spinal cord injury. J. Neurotrauma14(8), 517–537 (1997).
   PubMed Web of Science ®Google Scholar
• Christensen MD, Everhart AW, Pickelman JT, Hulsebosch CE. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain68(1), 97–107 (1996).
   PubMed Web of Science ®Google Scholar
• Bennett AD, Chastain KM, Hulsebosch CE. Alleviation of mechanical and thermal allodynia by CGRP(8–37) in a rodent model of chronic central pain. Pain86(1–2), 163–175 (2000).
   PubMed Web of Science ®Google Scholar
• Ding Q, Wu Z, Guo Y et al. Proteome analysis of up-regulated proteins in the rat spinal cord induced by transection injury. Proteomics6(2), 505–518 (2006).
   PubMed Web of Science ®Google Scholar
• O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem.250(10), 4007–4021 (1975).
   PubMed Web of Science ®Google Scholar
• Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem.203(1), 173–179 (1992).
   PubMed Web of Science ®Google Scholar
• Burre J, Beckhaus T, Corvey C et al. Synaptic vesicle proteins under conditions of rest and activation: analysis by 2-D difference gel electrophoresis. Electrophoresis27(17), 3488–3496 (2006).
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Komori N. Protein identification on two-dimensional gels archived nearly two decades ago by in-gel digestion and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal. Biochem.270(1), 176–179 (1999).
   PubMedGoogle Scholar
• Kim KJ, Yoon YW, Chung JM. Comparison of three rodent neuropathic pain models. Exp. Brain Res.113(2), 200–206 (1997).
   PubMed Web of Science ®Google Scholar
• Lee DH, Chung K, Chung JM. Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model. Neuroreport8(16), 3453–3456 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang YH, Zhang XH et al. Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats. Exp. Brain Res. (2008).
   Google Scholar
• Lee SC, Yoon TG, Yoo YI et al. Analysis of spinal cord proteome in the rats with mechanical allodynia after the spinal nerve injury. Biotechnol. Lett.25(24), 2071–2078 (2003).
   PubMedGoogle Scholar
• Alzate O, Hussain SR, Goettl VM et al. Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. Brain Res. Mol. Brain Res.128(2), 193–200 (2004).
   PubMedGoogle Scholar
• Komori N, Takemori N, Kim HK et al. Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: altered protein regulation following segmental spinal nerve ligation injury. Physiol. Genomics29(2), 215–230 (2007).
   PubMedGoogle Scholar
• Sullivan PG, Geiger JD, Mattson MP, Scheff SW. Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol.48(5), 723–729 (2000).
   PubMed Web of Science ®Google Scholar
• Klivenyi P, Ferrante RJ, Matthews RT et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med.5(3), 347–350 (1999).
   PubMed Web of Science ®Google Scholar
• Xu CJ, Klunk WE, Kanfer JN et al. Phosphocreatine-dependent glutamate uptake by synaptic vesicles. A comparison with atp-dependent glutamate uptake. J. Biol. Chem.271(23), 13435–13440 (1996).
   PubMed Web of Science ®Google Scholar
• Arimura N, Menager C, Fukata Y, Kaibuchi K. Role of CRMP-2 in neuronal polarity. J. Neurobiol.58(1), 34–47 (2004).
   PubMedGoogle Scholar
• Katano T, Mabuchi T, Okuda-Ashitaka E et al. Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics6(22), 6085–6094 (2006).
   PubMedGoogle Scholar
• Kunz S, Tegeder I, Coste O et al. Comparative proteomic analysis of the rat spinal cord in inflammatory and neuropathic pain models. Neurosci. Lett.381(3), 289–293 (2005).
   PubMed Web of Science ®Google Scholar
• Beattie MS, Farooqui AA, Bresnahan JC. Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma17(10), 915–925 (2000).
   PubMed Web of Science ®Google Scholar
• Profyris C, Cheema SS, Zang D et al. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis.15(3), 415–436 (2004).
   PubMed Web of Science ®Google Scholar
• Kang SK, So HH, Moon YS, Kim CH. Proteomic analysis of injured spinal cord tissue proteins using 2-DE and MALDI-TOF MS. Proteomics6(9), 2797–2812 (2006).
   PubMedGoogle Scholar
• Conti A, Ricchiuto P, Iannaccone S et al. Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies. Proteomics5(17), 4558–4567 (2005).
   PubMed Web of Science ®Google Scholar
• Pasinetti GM, Ungar LH, Lange DJ et al. Identification of potential CSF biomarkers in ALS. Neurology66(8), 1218–1222 (2006).
   PubMed Web of Science ®Google Scholar
• D’Aguanno S, Barassi A, Lupisella S et al. Differential cerebrospinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis. J. Neuroimmunol.193(1–2), 156–160 (2008).
   PubMed Web of Science ®Google Scholar
• Costigan M, Befort K, Karchewski L et al. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci.3, 16 (2002).
   PubMed Web of Science ®Google Scholar
• Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol. Neurobiol.14(1–2), 67–116 (1997).
   PubMed Web of Science ®Google Scholar
• Fournier AE, McKerracher L. Expression of specific tubulin isotypes increases during regeneration of injured CNS neurons, but not after the application of brain-derived neurotrophic factor (BDNF). J. Neurosci.17(12), 4623–4632 (1997).
   PubMedGoogle Scholar
• Baldwin SA, Broderick R, Blades DA, Scheff SW. Alterations in temporal/spatial distribution of GFAP- and vimentin-positive astrocytes after spinal cord contusion with the New York University spinal cord injury device. J. Neurotrauma15(12), 1015–1026 (1998).
   PubMed Web of Science ®Google Scholar
• Willis D, Li KW, Zheng JQ et al. Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J. Neurosci.25(4), 778–791 (2005).
   PubMed Web of Science ®Google Scholar
• Perlson E, Hanz S, Ben-Yaakov K et al. Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron45(5), 715–726 (2005).
   PubMed Web of Science ®Google Scholar
• Sharma HS, Gordh T, Wiklund L, Mohanty S, Sjoquist PO. Spinal cord injury induced heat-shock protein expression is reduced by an antioxidant compound H-290/51. An experimental study using light and electron microscopy in the rat. J. Neural Transm.113(4), 521–536 (2006).
   PubMed Web of Science ®Google Scholar
• Yenari MA, Giffard RG, Sapolsky RM, Steinberg GK. The neuroprotective potential of heat-shock protein 70 (HSP70). Mol. Med. Today5(12), 525–531 (1999).
   PubMedGoogle Scholar
• Costigan M, Mannion RJ, Kendall G et al. Heat-shock protein 27: developmental regulation and expression after peripheral nerve injury. J. Neurosci.18(15), 5891–5900 (1998).
   PubMed Web of Science ®Google Scholar
• Kretz A, Schmeer C, Tausch S, Isenmann S. Simvastatin promotes heat-shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo. Neurobiol. Dis.21(2), 421–430 (2006).
   PubMedGoogle Scholar
• Latchman DS. HSP27 and cell survival in neurones. Int. J. Hyperthermia21(5), 393–402 (2005).
   PubMed Web of Science ®Google Scholar
• Weber CA, Ernst ME. Antioxidants, supplements, and Parkinson’s disease. Ann. Pharmacother.40(5), 935–938 (2006).
   PubMedGoogle Scholar
• Pham DQ, Plakogiannis R. Vitamin E supplementation in Alzheimer’s disease, Parkinson’s disease, tardive dyskinesia, and cataract: part 2. Ann. Pharmacother.39(12), 2065–2072 (2005).
   PubMedGoogle Scholar
• Hinault MP, Ben-Zvi A, Goloubinoff P. Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J. Mol. Neurosci.30(3), 249–265 (2006).
   PubMed Web of Science ®Google Scholar
• Obata K, Yamanaka H, Kobayashi K et al. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J. Neurosci.24(45), 10211–10222 (2004).
   PubMed Web of Science ®Google Scholar
• Mao J, Price DD, Mayer DJ, Hayes RL. Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury. Brain Res.588(1), 144–149 (1992).
   PubMed Web of Science ®Google Scholar
• Scholz J, Woolf CJ. Can we conquer pain? Nat. Neurosci.5(Suppl.), 1062–1067 (2002).
   PubMed Web of Science ®Google Scholar
• Beyreuther BK, Freitag J, Heers C et al. Lacosamide: a review of preclinical properties. CNS Drug Rev.13(1), 21–42 (2007).
   PubMedGoogle Scholar